share_log

Johnson & Johnson | 424B2: Prospectus

Johnson & Johnson | 424B2: Prospectus

強生 | 424B2：募資說明書
美股sec公告 ·  05/16 16:21
Moomoo AI 已提取核心訊息
Johnson & Johnson (JNJ.US), a leading healthcare company, has announced the issuance of a series of senior unsecured notes under its existing shelf registration. The notes, denominated in euros, are offered in three tranches: €700 million at 3.200% due 2032, €800 million at 3.350% due 2036, and €1 billion at 3.550% due 2044. Interest on these notes will be paid annually beginning June 1, 2024. The notes are expected to be listed on the New York Stock Exchange and are intended to be used for general corporate purposes, which may include funding the acquisition of Shockwave Medical, Inc. The offering is managed by a consortium of banks, including J.P. Morgan, Citigroup, and Deutsche Bank, acting as joint book-running managers. The issuance is subject to customary closing conditions and is expected to settle on May 20, 2024.
Johnson & Johnson (JNJ.US), a leading healthcare company, has announced the issuance of a series of senior unsecured notes under its existing shelf registration. The notes, denominated in euros, are offered in three tranches: €700 million at 3.200% due 2032, €800 million at 3.350% due 2036, and €1 billion at 3.550% due 2044. Interest on these notes will be paid annually beginning June 1, 2024. The notes are expected to be listed on the New York Stock Exchange and are intended to be used for general corporate purposes, which may include funding the acquisition of Shockwave Medical, Inc. The offering is managed by a consortium of banks, including J.P. Morgan, Citigroup, and Deutsche Bank, acting as joint book-running managers. The issuance is subject to customary closing conditions and is expected to settle on May 20, 2024.
領先的醫療保健公司強生公司（JNJ.US）宣佈根據其現有貨架註冊發行一系列優先無擔保票據。這些票據以歐元計價，分三批發行：7億歐元，利率3.200％，2032年到期；8億歐元，2036年到期，3.350％；10億歐元，2044年到期，3.550％。從2024年6月1日起，這些票據的利息將每年支付。這些票據預計將在紐約證券交易所上市，用於一般公司用途，其中可能包括爲收購Shockwave Medical, Inc.提供資金。此次發行由包括摩根大通、花旗集團和德意志銀行在內的銀行財團管理，擔任聯席賬面管理人。本次發行受慣例成交條件的約束，預計將於2024年5月20日結算。
領先的醫療保健公司強生公司（JNJ.US）宣佈根據其現有貨架註冊發行一系列優先無擔保票據。這些票據以歐元計價，分三批發行：7億歐元，利率3.200％，2032年到期；8億歐元，2036年到期，3.350％；10億歐元，2044年到期，3.550％。從2024年6月1日起，這些票據的利息將每年支付。這些票據預計將在紐約證券交易所上市，用於一般公司用途，其中可能包括爲收購Shockwave Medical, Inc.提供資金。此次發行由包括摩根大通、花旗集團和德意志銀行在內的銀行財團管理，擔任聯席賬面管理人。本次發行受慣例成交條件的約束，預計將於2024年5月20日結算。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息